AzTrials
AzTrials

TMJNCT06936072

Temporomandibular Joint Eminence Augmentation Using Titanium Ring Inlay: A New Surgical Technique

A study testing Titanium Ring Inlay Eminence Augmentation in people with TMJ and Augmentation, run by Sinai University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To evaluate the efficacy of titanium ring inlay in ESS technique in Temporomandibular joint eminence augmentation Read more about this study

Who is it for?
Ages 25 to 41 years
What is being tested?
Titanium Ring Inlay Eminence Augmentation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
112 participants
Where
1 siteEgypt
Study dates
28 Apr 2024to 3 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 41 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Diagnosed TMJ dysfunction requiring eminence augmentation
  • Failed conservative management (≥3 months)
  • Adequate bone stock for inlay placement
  • Willingness to comply with follow-up protocol

Who cannot join

  • Systemic conditions contraindicating surgery
  • Active TMJ infection
  • Previous TMJ surgery
  • Pregnancy
  • Neuromuscular disorders-

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Menoufia University, Faculty of Medicine, University Hospital

    Menoufia University

Other trials in Egypt

About this study

To evaluate the efficacy of titanium ring inlay in ESS technique in Temporomandibular joint eminence augmentation

Read the detailed description

Background:Temporomandibular joint (TMJ) disorders affect approximately 5-12% of the population, with eminence augmentation being a challenging surgical intervention. Current techniques using autogenous grafts or alloplastic materials present limitations including donor site morbidity, resorption, and implant failure. This study evaluates a novel titanium ring inlay technique for TMJ eminence augmentation, which may offer improved stability, osseointegration, and functional outcomes.

Patients and Methods: A prospective study was conducted on 100 patients (28 males, 72 females; age range: 25-41 years) with TMJ Temporomandibular joint eminence augmentation. Study was performed after ethical approval from Research Ethics Committee, Faculty of Dentistry, Sinai University OMS 01-04-024; . Titanium ring inlay procedure was performed to Temporomandibular joint eminence augmentation. Preoperative and postoperative assessments included pain levels (VAS pain), maximum mouth opening (MMO), Clicking during mouth opening, Headach presence, tinnitus and subjective patient feedback.

Being tested
Titanium Ring Inlay Eminence Augmentation
Keywords
TMJ, TMJ augmentation, Augmentation, Oral and Maxillofacial surgery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Titanium Ring Inlay Eminence AugmentationProcedure or surgery

    • Preauricular approach with subperiosteal dissection
    • Dual osteotomy (transverse mid-eminence + vertical parallel to skull base)
    • Titanium ring inlay placement with anatomical contouring
    • Intraoperative functional assessment
Study groups in NCT06936072
Study groupRoleWhat they receive
Titanium Ring Inlay Eminence Augmentation GroupExperimentalProcedure: Novel titanium ring inlay eminence augmentation via modified ESS technique Inverted L-shaped osteotomy with controlled greenstick fracture Precise titanium ring (12-15mm diameter) implantation Surgical Protocol: * Preauricular approach with subperiosteal dissection * Dual osteotomy (transverse mid-eminence + vertical parallel to skull base) * Titanium ring inlay placement with anatomical contouring * Intraoperative functional assessment Postoperative Care: * Standardized analgesic protocol * Physiotherapy protocol initiation at 2 weeks * Gradual return to function protocol Follow-up Schedule: * Clinical assessments at 5 timepoints (T0-T4) * Standardized outcome measurements (VAS, MIO, etc.) Key Characteristics: Single-arm interventional design All participants receive identical surgical protocol Standardized outcome assessment methodology Blinded evaluators for outcome measures (where applicable) Rationale for Single Arm Design: First-in-human evaluation of nov
Receives: Procedure: Titanium Ring Inlay Eminence Augmentation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional improvement

    Measuring the Maximal interincisal opening (MIO; mm)

    Measured: Baseline (T0); T1 (1 months postoperative); T2 (3 months postoperative); T3 (6 months postoperative); T4 (12 months postoperative).

Secondary outcomes (3)
  1. Pain Score

    Measuring the Visual Analogue Scale (VAS), pain score (1-10)

    Measured: Baseline (T0); T1 (1 months postoperative); T2 (3 months postoperative); T3 (6 months postoperative); T4 (12 months postoperative).

  2. Headache

    Measuring the Headache Assessment Presence Yes/No

    Measured: Baseline (T0); T1 (1 months postoperative); T2 (3 months postoperative); T3 (6 months postoperative); T4 (12 months postoperative).

  3. Tinnitus

    Tinnitus presence (Y/N)

    Measured: Baseline (T0); T1 (1 months postoperative); T2 (3 months postoperative); T3 (6 months postoperative); T4 (12 months postoperative).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Apr 2025
  2. Study start28 Apr 2024
  3. Primary completion3 Apr 2025
  4. Study completion3 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
A prospective study was conducted on 100 patients (28 males, 72 females; age range: 25-41 years) with TMJ Temporomandibular joint eminence augmentation. Study was performed after ethical approval from Research Ethics Committee, Faculty of Dentistry, Sinai University OMS 01-04-024.
Masking
None (open label)
Enrolment
112 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06936072
Sponsor's protocol ID
OMS 1-04-024
Status last verified
Apr 2025
First submitted
5 Apr 2025
Last updated
20 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: A prospective study was conducted on 100 patients (28 males, 72 females; age range: 25-41 years) with TMJ Temporomandibular joint eminence augmentation. Study was performed after ethical approval from Research Ethics Committee.

Questions about this trial

What is this clinical trial studying?

A study testing Titanium Ring Inlay Eminence Augmentation in people with TMJ and Augmentation, run by Sinai University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional improvement (time frame: Baseline (T0); T1 (1 months postoperative); T2 (3 months postoperative); T3 (6 months postoperative); T4 (12 months postoperative).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Apr 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in